Menu Search
Equities

Plus Therapeutics Inc

XMP0:FRA

Plus Therapeutics Inc

Actions
  • Price (EUR)1.38
  • Today's Change-0.05 / -3.50%
  • Shares traded20.00
  • 1 Year change+16.95%
  • Beta0.4206
Data delayed at least 15 minutes, as of Sep 20 2024 07:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Plus Therapeutics Inc's revenues fell -27.85% from 14.73m to 10.63m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 23.22m to a larger loss of 27.49m.
Gross margin--
Net profit margin-240.15%
Operating margin-256.07%
Return on assets-104.14%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

SmartText is unavailable
Cash flow per share-2.72
Price/Cash flow per share--
Book value per share-1.34
Tangible book value per share-1.50
More ▼

Balance sheet in USDView more

SmartText is unavailable
Current ratio0.4993
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.